• PRALATREXATE chembl:CHEMBL1201746 ApprovedAntineoplasticImmunotherapy

    Alternate Names:

    PDX
    PRALATREXATE
    FOLOTYN
    N-(4-(1-((2,4-DIAMINO-6-PTERIDINYL)METHYL)-3-BUTYNYL)BENZOYL)-L-GLUTAMIC ACID
    HSDB 7786
    (2S)-2-((4-((1RS)-1-((2,4-DIAMINOPTERIDIN-6-YL)METHYL)BUT-3-YNYL)BENZOYL)AMINO)PENTANEDIOIC ACID
    PRALATREXATUM
    FOLOTYN®
    PRALATREXATO
    (2S)-2-({4-[1-(2,4-DIAMINOPTERIDIN-6-YL)PENT-4-YN-2-YL]BENZOYL}AMINO)PENTANEDIOIC ACID
    10-PROPARGYL-10-DEAZAAMINOPTERIN
    pubchem.compound:148121
    rxcui:662019
    chembl:CHEMBL1201746
    drugbank:06813
    chemidplus:146464-95-1

    Drug Info:

    Year of Approval 2009
    Drug Class antineoplastic agents
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    FDA Approval 2009
    Drug Indications Antineoplastic Agents
    Drug Categories folic acid analogues
    Drug Groups investigational
    Drug Categories bcrp/abcg2 substrates
    Drug Categories drugs that are mainly renally excreted
    Drug Categories heterocyclic compounds, fused-ring
    Drug Categories narrow therapeutic index drugs
    (5 More Sources)